Medicated Skin Products Market in South Africa to 2014 (OTC Healthcare)

Introduction

This databook provides key data and information on the Medicated Skin Products Market in South Africa (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

*Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
*Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights


The medicated skin products category was valued at ZAR308m ($37.3m) in 2009, representing a CAGR of 6.4% since 2004.

By the end of 2014, the medicated skin products category will be worth ZAR390.4m ($47.3m), with an expected CAGR of 4.9% between 2009 and 2014.

The medicated skin products market was led by anti-fungals (representing 28.8% of the total value) followed by other medicated skin products and acne treatments, with a 21.2% and 17.1% market share, respectively. Disinfectants and anti-bacterials constitute the remaining segments with a 16.9% and 16.1% market share, respectively.

Environ Skin Care (Pty) Ltd is the market leader with a 17.2% share of the market.


Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the Medicated Skin Products Market in South Africa (OTC Healthcare)

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary category level: medicated skin products 2
Chapter 2 Definition 3
Chapter 3 Category Analysis: Medicated Skin Products 8
Value analysis (South African Rand), 2004?09 8
Value analysis (South African Rand), 2009?14 9
Value analysis (US dollars), 2004?09 11
Value analysis (US dollars), 2009?14 12
Company and brand share analysis 14
Distribution analysis 16
Chapter 4 Macroeconomic Profile 18
Macroeconomic Indicators 18
Chapter 5 Research Methodology 23
Methodology overview 23
Secondary research 24
Market modeling 25
Creating an initial data model 25
Revising the initial data model 25
Creating a final estimate 26
Creating demographic value splits 26
Primary research 26
Data finalization 27
Ongoing research 27

LIST OF FIGURES
Figure 1: Medicated skin products, South Africa, value by segment (ZARm), 2004?14 10
Figure 2: Medicated skin products, South Africa, category growth comparison, by value, 2004?14 13
Figure 3: Medicated skin products, South Africa, distribution channels by value (%), 2008?09 17
Figure 4: Annual data review process 24

LIST OF TABLES
Table 1: Medicated skin products category definitions 3
Table 2: Medicated skin products distribution channels 4
Table 3: Medicated skin products, South Africa, value by segment (ZARm), 2004?09 8
Table 4: Medicated skin products, South Africa, value forecast by segment (ZARm), 2009?14 9
Table 5: Medicated skin products, South Africa, value by segment ($m), 2004?09 11
Table 6: Medicated skin products, South Africa, value forecast by segment ($m), 2009?14 12
Table 7: Medicated skin products, South Africa, brand share by value (%), 2008?09 14
Table 8: Medicated skin products, South Africa, value by brand (ZARm), 2008?09 14
Table 9: Medicated skin products, South Africa, company share by value (%), 2008?09 15
Table 10: Medicated skin products, South Africa, value by company (ZARm), 2008?09 15
Table 11: Medicated skin products, South Africa, distribution channels by value (%), 2008?09 16
Table 12: Medicated skin products, South Africa, value by distribution channel (ZARm), 2008?09 16
Table 13: South Africa population, by age group, 2004?09 (millions) 18
Table 14: South Africa population forecast, by age group, 2009?14 (millions) 19
Table 15: South Africa population, by gender, 2004?09 (millions) 19
Table 16: South Africa population forecast, by gender, 2009?14 (millions) 20
Table 17: South Africa nominal GDP, 2004?09 (ZARbn, nominal prices) 20
Table 18: South Africa nominal GDP forecast, 2009?14 (ZARbn, nominal prices) 20
Table 19: South Africa real GDP, 2004?09 (ZARbn, 2000 prices) 21
Table 20: South Africa real GDP forecast, 2009?14 (ZARbn, 2000 prices) 21
Table 21: South Africa real GDP, 2004?09 ($bn, 2000 prices) 21
Table 22: South Africa real GDP forecast, 2009?14 ($bn, 2000 prices) 22
Table 23: South Africa consumer price index, 2004?09 (2000=100) 22
Table 24: South Africa consumer price index, 2009?14 (2000=100) 22


[Inhaltsverzeichnis ausblenden]